Our final funding round will offer up to 10% of AGI Laboratory shares. Offers will be considered according to the following criteria:
All shares in AGI Laboratory are common stock with voting rights, and proposed additions to our team made by a major investor will be seriously considered, including as part of the investment process.
For the Norn White Paper, Supplemental Materials, and Technical Summary go to our Documents Page. For access to more documents relating to our research, systems, business plan, and financial projections please contact us using the form below.